Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Nitriles. Found 5 abstracts

Hurwitz MD, Harris J, Sartor O, Xiao Y, Shayegan B, Sperduto PW, Badiozamani KR, Lawton CA, Horwitz EM, Michalski JM, Roof K, Beyer DC, Zhang Q, Sandler HM. Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621. Cancer. 2017 Jul;123(13):2489-96.   PMCID: PMC5474197
Fan L, Liedke PE, Isakoff SJ, St Louis J, Ryan PD, Goss PE. Intermittent letrozole therapy for metastatic breast cancer: case reports and literature review. Clin Breast Cancer. 2014 Apr;14(2):e41-5.
Cristofanilli M, Valero V, Mangalik A, Royce M, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Bacus S, Cora EM, Anderson E, Magill PJ. Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer. Clinical Cancer Research. 2010 Mar 15;16(6):1904-14.   PMCID: NIHMS352308
Chen JQ, Russo PA, Cooke C, Russo IH, Russo J. ERbeta shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins. Biochimica et biophysica acta. 2007 Dec;1773(12):1732-46.
Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol. 2002 Aug;20(15):3317-27.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Nitriles

Nitriles pathology therapeutic use Female Breast Neoplasms Triazoles drug therapy Aged metabolism Hormone-Dependent Neoplasms Postmenopause enzymology Adult Neoplasm Staging Disease-Free Survival Middle Aged Estrogen Receptors antagonists & inhibitors Aromatase administration & dosage Multicenter Studies as Topic Mice Tissue Distribution Electron Transport Neoplasm Grading Proportional Hazards Models Enzyme Inhibitors Taxoids Prostatectomy Propionates Anilides postprostatectomy Prostatic Neoplasms Evidence-Based Medicine docetaxel Antineoplastic Combined Chemotherapy Protocols Estrogen Receptor beta chemotherapy Adjuvant Chemotherapy Non-US Gov't Support Subcellular Fractions Kallikreins Progesterone Receptors therapy Intensity-Modulated Radiotherapy Prospective Studies Protein Transport Gene Silencing biosynthesis Treatment Outcome drug effects ultrastructure Survival Analysis Neoplasm Metastasis pharmacology Mitochondria Mitochondrial Proteins Epithelial Cells methods high risk Hormonal Antineoplastic Agents Epidermal Growth Factor Receptor Aromatase inhibitor Disease resistance Adenocarcinoma Randomized Controlled Trials Male Double-Blind Method Review Literature as Topic Cell Nucleus Estrogens Human Quinazolines Tamoxifen blood Breast agonists Antineoplastic Agents Discontinuous therapy Androgen Antagonists androgen deprivation Expert Testimony Antineoplastic Combined Chemotherapy Protocols Gonadotropin-Releasing Hormone Electron Transport Complex IV Prognosis Conformal Radiotherapy pharmacokinetics Multivariate Analysis 80 and over Aged Tosyl Compounds secondary Prostate-Specific Antigen Lymphatic Metastasis radiation erbB-2 Receptor Adjuvant Chemoradiotherapy Cell Line Aromatase Inhibitors Phase II Clinical Trials as Topic Survival Rate Neoplastic Cell Transformation
Last updated on Wednesday, February 05, 2020